Significance of Cytokeratin Fragment M65 and Cytokines IL6, IL8 and IL17A in Bone Marrow Aspirates of Colorectal Cancer Patients

References (40)

1. 1 The Interleukin-8 Pathway in Cancer [DOI]
2. 2 A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer [DOI]
3. 3 Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments [DOI]
4. 4 Circulating tumour cells in cancer patients: challenges and perspectives [DOI]
5. 5 Micrometastases and Survival in Stage II Colorectal Cancer [DOI]
6. 6 The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance [DOI]
7. 7 Endogenous IL-17 contributes to reduced tumor growth and metastasis [DOI]
8. 8 Interleukin-6 in bone metastasis and cancer progression [DOI]
9. 9 Interleukin-17 and its expanding biological functions [DOI]
10. 10 Review: Biological relevance of disseminated tumor cells in cancer patients [DOI]
11. 11 Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
12. 12 Chronic inflammation, the tumor microenvironment and carcinogenesis [DOI]
13. 13 Circulating Tumor Cells and Bone Marrow Micrometastasis [DOI]
14. 14 Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables [DOI]
15. 15 High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas [DOI]
16. 16 Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor‐infiltrating lymphocytes, tumor‐draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer [DOI]
17. 17 Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review [DOI]
18. 18 Th17 cells: positive or negative role in tumor? [DOI]
19. 19 Disseminated and circulating tumor cells: Role in effective cancer management [DOI]
20. 20 Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker [DOI]
21. 21 Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression [DOI]
22. 22 A significant soluble keratin fraction in ‘simple’ epithelial cells Lack of an apparent phosphorylation and glycosylation role in keratin solubility [DOI]
23. 23 A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients [DOI]
24. 24 Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
25. 25 Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies [DOI]
26. 26 Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma [DOI]
27. 27 Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients [DOI]
28. 28 Stage II and Stage III Colon Cancer [DOI]
29. 29 Expression of interleukin-17 in human colorectal cancer.
30. 30 Locally Advanced Rectal Cancer [DOI]
31. 31 Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer [DOI]
32. 32 Circulating Cytokeratin 18 Fragment M65—A Potential Marker of Malignancy in Colorectal Cancer Patients [DOI]
33. 33 Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study [DOI]
34. 34 Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. [DOI]
35. 35 Control of tumor development by intratumoral cytokines [DOI]
36. 36 Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer [DOI]
37. 37 The impact of bone marrow micrometastases on metastatic disease‐free survival in patients with colorectal carcinoma [DOI]
38. 38 Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patients (Review) [DOI]
39. 39 Transcription of Cytokeratins 8, 18, and 19 in Bone Marrow and Limited Expression of Cytokeratins 7 and 20 by Carcinoma Cells: Inherent Limitations for RT-PCR in the Detection of Isolated Tumor Cells [DOI]
40. 40 Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19 [DOI]

Cited by 3

Related research

• Colorectal Cancer Risk and Prevention Knowledge among Adults Attending Public Health Facilities in Obudu, Cross River State, Nigeria — shares topic coverage
• The Use of Complete Blood Count as Inflammatory Biomarkers in Patients with Colorectal Cancers in Enugu State University of Science and Technology Teaching Hospital, Parklane Enugu — shares topic coverage
• Demographic and Histopathological Spectrum of Gastrointestinal Cancers Excluding Hepatobiliary System: A 10-Year Review from Makurdi, North Central Nigeria — shares topic coverage
• Fecal and Salivary Microbial Gene Markers for the Non-invasive Detection of Colorectal Cancer Progression — shares topic coverage
• Can Noninvasive Tests Substitute Endoscopy for Diagnosis of Colonic Diseases? — shares topic coverage